Search results
Results from the WOW.Com Content Network
Thyroid hormones, another early weight loss drug, also raised energy expenditure but ceased to be used for weight loss due to cardiac risks and other adverse effects. [18] Selective thyromimetics that work on the thyroid hormone receptor beta may be able to exert some of the beneficial thermogenic effects of thyroid hormones with fewer adverse ...
Regadenoson, sold under the brand name Lexiscan among others, is an A 2A adenosine receptor agonist that is a coronary vasodilator that is commonly used in pharmacologic stress testing. It produces hyperemia quickly and maintains it for a duration that is useful for radionuclide myocardial perfusion imaging . [ 1 ]
[84] [85] Preoperative weight loss can reduce operative time and hospital stay. [84] [86] [87] although there is insufficient evidence whether preoperative weight loss may be beneficial to reduce long-term morbidity or complications. [87] [88] Weight loss and decreases in liver size may be independent from the amount of calorie restriction. [85]
Orlistat is used for the treatment of obesity.The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat.
Unintended weight loss of more than 5% within 6 months. [2] [20] For patients with a body mass index of less than 20 kg/m 2, cachexia is diagnosed after the unintended weight loss of more than 2%. [2] [20] [28] In patients with sarcopenia, cachexia is diagnosed by a weight loss of more than 2%. [2] [20] [28]
The approximate relative levels of the preventable causes of cancer in the United States, taken from the article Cancer prevention. About 75-80% of all cancers in the United States are preventable, if risk factors are avoided [4] (also see (Cancer prevention). Obesity appears to be the third most important risk factor for cancer in the United ...
Intentional weight loss is the loss of total body mass as a result of efforts to improve fitness and health, or to change appearance through slimming. Weight loss is the main treatment for obesity, [1] [2] [3] and there is substantial evidence this can prevent progression from prediabetes to type 2 diabetes with a 7–10% weight loss and manage cardiometabolic health for diabetic people with a ...
In March 2023, a Novo Nordisk official said, based on a randomized, double-blind study (NCT03548935 [107]) funded by the company, that patients using semaglutide to lose weight regained two-thirds of their original weight loss one year (52 weeks) after discontinuing use of the drug. After two years (120 weeks), the patients retained roughly one ...